PBS Newshour - September 17, 2019
Alan Shapiro, M.D., discusses the harmful physical and mental effects of detaining migrant children in government detention facilities. Dr. Shapiro is clinical assistant professor of pediatrics at Einstein and senior medical director of community pediatrics programs at Children's Hospital at Montefiore.
Dr. Shapiro's Profile
Science - September 16, 2019
Research by Paul Frenette, M.D., has advanced what we know about how nerves spur the development and spread of prostate cancer. His new research investigates how beta blockers, which target the nervous system, may help treat cancer. Dr. Frenette is professor of medicine and of cell biology, and chair and director of the Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research.
Dr. Frenette's ProfileMore coverage on Dr. Frenette
The Scientist - September 10, 2019
David Q.H. Wang, M.D., Ph.D., details the limitations of a study that claims sticky clumps of DNA and protein extruded by immune cells help gallstones form. Dr. Wang is professor of medicine and of genetics at Einstein.
Dr. Wang's Profile
Science - August 8, 2019
Harris Goldstein, M.D., describes his new research, in Science Translational Medicine, that uses genetically reprogrammed T cells to successfully fight HIV infection in mice. Dr. Goldstein is professor of pediatrics and of microbiology & immunology and director of the Einstein-Rockefeller-CUNY Center for AIDS Research.
Dr. Goldstein's ProfileMore coverage on Dr. Goldstein
The Atlantic - July 15, 2019
Eric Hollander, M.D., comments on how ingesting the eggs of the parasitic worm Trichuris suis may affect the gut microbiome and improve repetitive behavior, rigidity, and irritability in people with autism spectrum disorder. Dr. Hollander is professor of psychiatry and behavioral sciences at Einstein and director of the Autism and Obsessive Compulsive Spectrum Program at Einstein and Montefiore.
Dr. Hollander's ProfileMore coverage on Dr. Hollander
CBS New York - July 12, 2019
Richard Lipton, M.D., discusses his New England Journal of Medicine study on rimegepant, a drug belonging to a new generation of acute migraine headache treatments that was found to eliminate pain and reduce bothersome symptoms. Dr. Lipton is Edwin S. Lowe Professor and vice chair of the Saul R. Korey Department of Neurology at Einstein and director of the Montefiore Headache Center.
More Coverage on this Story
US News & World Report (via HealthDay)
Dr. Lipton's ProfileMore coverage on Dr. Lipton